Skip to main content
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
53.88
+1.65 (3.16%)
Aug 13, 2025, 4:00 PM - Market closed

Haemonetics Revenue

Haemonetics had revenue of $321.39M in the quarter ending June 28, 2025, a decrease of -4.40%. This brings the company's revenue in the last twelve months to $1.35B, up 0.91% year-over-year. In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth.

Revenue (ttm)
$1.35B
Revenue Growth
+0.91%
P/S Ratio
1.99
Revenue / Employee
$445,268
Employees
3,023
Market Cap
2.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 29, 20251.36B51.77M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020 Pro Pro Pro
Mar 30, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro
Apr 2, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings

HAE News

More News